Angiomax en es it fr

Angiomax Brand names, Angiomax Analogs

Angiomax Brand Names Mixture

  • Tavist-D Tablets (Clemastine + Phenylpropanolamine Hydrochloride)

Angiomax Chemical_Formula


Angiomax RX_link

Angiomax fda sheet

Angiomax FDA

Angiomax msds (material safety sheet)

Angiomax Synthesis Reference

No information avaliable

Angiomax Molecular Weight


Angiomax Melting Point

No information avaliable

Angiomax H2O Solubility

No information avaliable

Angiomax State


Angiomax LogP


Angiomax Dosage Forms

Solution (IV Injection and Infusion)

Angiomax Indication

For treatment of heparin-induced thrombocytopenia

Angiomax Pharmacology

Angiomax directly inhibits thrombin by specifically binding both to the catalytic site and to the anion-binding exosite of circulating and clot-bound thrombin. Thrombin is a serine proteinase that plays a central role in the thrombotic process, acting to cleave fibrinogen into fibrin monomers and to activate Factor XIII to Factor XIIIa, allowing fibrin to develop a covalently cross-linked framework which stabilizes the thrombus; thrombin also activates Factors V and VIII, promoting further thrombin generation, and activates platelets, stimulating aggregation and granule release

Angiomax Absorption

No information avaliable

Angiomax side effects and Toxicity

No information avaliable

Angiomax Patient Information

No information avaliable

Angiomax Organisms Affected

Humans and other mammals